Ways to Control Myopia

Myopia has seen a significant global rise in recent decades. It advances most swiftly from ages 6 to early adulthood, underscoring the vital need for early monitoring and intervention. Detecting myopia early yields superior results. Below, explore supported methods to manage and curb myopia progression.

Axial Length Measurement

Once the eye has grown longer, there is no way we can shrink the eye again. Our treatment for myopia aims to reduce the rate of eye growth and in the best case, stop it altogether. It is of paramount importance that we regularly measure the axial length of your child’s eyes.

We at Sparks & Feros Optometrist, are fortunately able to measure axial length with our new IOL Master system which is fast painless and makes no contact with the eye.

Did you know?

Myopia occurs when the eye grows too long? We measure + monitor your child’s eye length.

IOL Master Biometry Assessment

Axial length biometry and charting over time is the gold standard of care to monitor the effectiveness of the your child myopia control treatment.

Charting Your Childs Eye Growth

 

Central optical zone surrounded by defocus area

New Spectacle Lenses to Treat Myopia

There are three new spectacle lenses that show promise in effectively slowing myopia. They are MiYosmart, Myo-Care and Stellest.

These special lenses can slow myopia progression by an average of 60-67%. These lenses uses a technology that has a clear central optical zone surrounded by many ‘defocus segments’. It is these “defocus segments” that help to control myopia progression.

 

 

Orthokeratology "Sleep Lenses"

Children wear ortho-k lenses while asleep and enjoy clarity of vision in the morning and throughout the day! This surgery-free correction to myopia, gently reshapes their corneas while they sleep and is recommended for children who need myopia control therapy but want to be free of wearing spectacles and contact lenses during day.

In recent decades, Orthokeratology has gained popularity, driven by accumulating evidence showing its effectiveness in not only providing short-term myopia correction but also in slowing down myopia progression over the long term.

 

 

Soft Multifocal Contact Lenses

Multifocal 1 Day contact lenses are now used as an effective option to reduce the progression of myopia. Like orthokeratology, these lenses blur the image that falls on the peripheral retina. This does nothing to compromise central vision and is not usually noticeable to the wearer, however, it is this peripheral defocus is the key to slowing down the progression of myopia.

 

 

 

Atropine Eye Drops

Recent studies such as the Atropine in the Treatment of Myopia (ATOM) project provide strong evidence to support the use of low concentration atropine eyedrops to retard the progression of myopia. Atropine is a prescription-only medication, the main effects of which are usual to dilate the pupil and relax the eye’s focusing (accommodation) system.

 

 

 

REPEATED LOW-LEVEL RED-LIGHT MYOPIA THERAPY AT HOME

Saving Sight Sooner Makes Brighter Futures

Repeated Low-Level Red-Light Myopia therapy at home has been shown to slow down the progression of myopia.
It does this by improving the metabolic rate and circulation of the eye. Repeated Low-Level Red-Light (RLRL) therapy, a highly effective and child-friendly way to slow the progression of myopia.

Designed to be easy and convenient to use at home, the therapy involves looking into the device for 3 minutes treatment, 2 times per day, 5 days per week, with a minimum of 4 hours between sessions. The device is controlled with a simple touchscreen and tracks each child’s use. It can also be monitored by the treating doctor and programmed to send SMS reminders to patient’s guardian.

 

 

 

Is This Device Safe?

It is free of any known significant side effects; and is suitable for use by children as young as 3 and up to 16. International approvals & regulatory status. The Eyerising Myopia Management Device meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and Australasia.*

How Effective is RLRL?

Clinically tested for trusted results The Eyerising Myopia Management Device has been proven in published clinical trials to be effective in the treatment of myopia, slowing its progression by up to 87.7%.
1 RLRL therapy’s efficacy and safety has been validated through a comprehensive ongoing clinical trial program. The results, published in leading peer-reviewed scientific publications show that with >75% compliance, exposure to RLRL therapy can control the progression of myopia.1